<code id='500411446E'></code><style id='500411446E'></style>
    • <acronym id='500411446E'></acronym>
      <center id='500411446E'><center id='500411446E'><tfoot id='500411446E'></tfoot></center><abbr id='500411446E'><dir id='500411446E'><tfoot id='500411446E'></tfoot><noframes id='500411446E'>

    • <optgroup id='500411446E'><strike id='500411446E'><sup id='500411446E'></sup></strike><code id='500411446E'></code></optgroup>
        1. <b id='500411446E'><label id='500411446E'><select id='500411446E'><dt id='500411446E'><span id='500411446E'></span></dt></select></label></b><u id='500411446E'></u>
          <i id='500411446E'><strike id='500411446E'><tt id='500411446E'><pre id='500411446E'></pre></tt></strike></i>

          hotspot

          hotspot

          author:fashion    Page View:1898
          A Medicare health insurance card on top of several hundred-dollar bills, with Benjamin Franklin's eyes covered by pills.
          Adobe

          The public will soon find out whether the federal government is willing to meet the health insurance industry’s demands and deposit more money into the bank accounts of next year’s Medicare Advantage plans.

          Budget officials within the Biden administration started reviewing final payment regulations for 2025 Medicare Advantage plans last week after more than 42,000 public comments rolled into the federal government’s inbox. Those rules will come out no later than April 1.

          advertisement

          In February, the government proposed a modest cut to next year’s average benchmark payment for Medicare Advantage plans, which are privately run insurance policies that now cover more than 33 million Americans. However, insurers are still estimated to receive more money under the proposal, overall, due to the aggressive way they code the medical conditions of their members.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Liver decline slowed by off
          Liver decline slowed by off

          AdobeWASHINGTON—TherearethreeFDA-approveddrugsfortreatingalcoholusedisorder.Butadifferentmedication,

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Change Healthcare: What is it, why does its cyberattack matter?

          AdobeThecyberattackonChangeHealthcarehasfracturedthecountry’shealthcarepaymentinfrastructure.Butital